{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:44:01Z","timestamp":1792205041821,"version":"4.4.0"},"reference-count":156,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009658","name":"American Pain Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018293","name":"Amryt Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018293","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jid.2023.05.024","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T09:42:55Z","timestamp":1686822175000},"page":"2108-2119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Type VII Collagen Deficiency in the Oncogenesis of Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7650-0835","authenticated-orcid":false,"given":"Andrew P.","family":"South","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6932-0374","authenticated-orcid":false,"given":"Martin","family":"Laimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1365-9074","authenticated-orcid":false,"given":"Mouhamed","family":"Gueye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2725-4230","authenticated-orcid":false,"given":"Jennifer Y.","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2760-0474","authenticated-orcid":false,"given":"Lawrence F.","family":"Eichenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2670-8117","authenticated-orcid":false,"given":"Jemima E.","family":"Mellerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-2240","authenticated-orcid":false,"given":"Alexander","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2023.05.024_bib2","doi-asserted-by":"crossref","first-page":"69321","DOI":"10.18632\/oncotarget.12504","article-title":"SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis","volume":"7","author":"Akamata","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2023.05.024_bib3","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.jid.2020.10.024","article-title":"Diversity of mechanisms underlying latent TGF-beta activation in recessive dystrophic epidermolysis bullosa","volume":"141","author":"Akasaka","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib4","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jid.2017.07.002","article-title":"Pro-inflammatory chemokines and cytokines dominate the blister fluid molecular signature in patients with epidermolysis bullosa and affect leukocyte and stem cell migration","volume":"137","author":"Alexeev","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001528","article-title":"Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa","volume":"94","author":"Annicchiarico","year":"2015","journal-title":"Med (Baltim)"},{"key":"10.1016\/j.jid.2023.05.024_bib6","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.0022-202X.2004.23418.x","article-title":"Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma","volume":"123","author":"Arbiser","year":"2004","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF03401916","article-title":"Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa","volume":"4","author":"Arbiser","year":"1998","journal-title":"Mol Med"},{"key":"10.1016\/j.jid.2023.05.024_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000218714","article-title":"Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa","volume":"219","author":"Arnold","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2023.05.024_bib9","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jid.2019.01.011","article-title":"Thrombospondin-1 is a major activator of TGF-beta signaling in recessive dystrophic epidermolysis bullosa fibroblasts","volume":"139","author":"Atanasova","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib10","doi-asserted-by":"crossref","first-page":"613438","DOI":"10.3389\/fimmu.2021.613438","article-title":"Latent TGF-beta activation is a hallmark of the tenascin family","volume":"12","author":"Aubert","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2023.05.024_bib11","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/ced.14592","article-title":"Evidence for cutaneous dysbiosis in dystrophic epidermolysis bullosa","volume":"46","author":"Bar","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jid.2023.05.024_bib13","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3390\/ijms20051119","article-title":"Nutrition and wound healing: an overview focusing on the beneficial effects of curcumin","volume":"20","author":"Barchitta","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2023.05.024_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-020-0210-0","article-title":"Epidermolysis bullosa","volume":"6","author":"Bardhan","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jid.2023.05.024_bib15","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1038\/s41467-019-10946-y","article-title":"Regulation of tumor angiogenesis and mesenchymal-endothelial transition by p38alpha through TGF-beta and JNK signaling","volume":"10","author":"Batlle","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2023.05.024_bib16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41586-022-04398-6","article-title":"Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA","volume":"602","author":"Bergstrom","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jid.2023.05.024_bib17","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114392","article-title":"Pro-inflammatory immunity supports fibrosis advancement in epidermolysis bullosa: intervention with Ang-(1\u20137)","volume":"13","author":"Bernasconi","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jid.2023.05.024_bib18","first-page":"5","article-title":"The myofibroblast in wound healing and fibrosis: answered and unanswered questions","author":"Bochaton-Piallat","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.jid.2023.05.024_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jid.2020.08.018","article-title":"QR-313, an antisense oligonucleotide, shows therapeutic efficacy for treatment of dominant and recessive dystrophic epidermolysis bullosa: a preclinical study","volume":"141","author":"Bornert","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib20","doi-asserted-by":"crossref","first-page":"10124","DOI":"10.1073\/pnas.88.22.10124","article-title":"A\u00a0role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma","volume":"88","author":"Brash","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jid.2023.05.024_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-019-1279-y","article-title":"The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers","volume":"15","author":"Bruckner","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2023.05.024_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.det.2009.10.020","article-title":"Dystrophic epidermolysis bullosa: pathogenesis and clinical features","volume":"28","author":"Bruckner-Tuderman","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jid.2023.05.024_bib23","doi-asserted-by":"crossref","unstructured":"Bruckner A, Tang J, Chung W, Morel K, Chen M, Woodley D, et\u00a0al. Collagen 7 (C7) protein replacement therapy (PTR-01) durably reduced wound size and symptoms in patients with recessive dystrophic epidermolysis bullosa (RDEB). Society for Investigative Dermatology Annual Meeting 2022.","DOI":"10.1016\/j.jid.2022.05.303"},{"key":"10.1016\/j.jid.2023.05.024_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/1523-1747.ep12365129","article-title":"Type VII collagen, anchoring fibrils, and epidermolysis bullosa","volume":"101","author":"Burgeson","year":"1993","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib25","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.1038\/ncomms12493","article-title":"Inactivation of TGFbeta receptors in stem cells drives cutaneous squamous cell carcinoma","volume":"7","author":"Cammareri","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2023.05.024_bib26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.matbio.2022.06.008","article-title":"Collagen VII maintains proteostasis in dermal fibroblasts by scaffolding TANGO1 cargo","volume":"111","author":"Cao","year":"2022","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jid.2023.05.024_bib27","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.0730640100","article-title":"Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells","volume":"100","author":"Castriconi","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jid.2023.05.024_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41525-021-00226-4","article-title":"The landscape of driver mutations in cutaneous squamous cell carcinoma","volume":"6","author":"Chang","year":"2021","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.jid.2023.05.024_bib29","first-page":"10","article-title":"APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa","author":"Cho","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2023.05.024_bib30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1600-0625.1999.tb00364.x","article-title":"Squamous cell carcinoma in a family with dominant dystrophic epidermolysis bullosa: a molecular genetic study","volume":"8","author":"Christiano","year":"1999","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib36","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.3390\/ijms20225707","article-title":"Epidermolysis bullosa-associated squamous cell carcinoma: from pathogenesis to therapeutic perspectives","volume":"20","author":"Condorelli","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2023.05.024_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12929-021-00732-8","article-title":"Notch-ing up knowledge on molecular mechanisms of skin fibrosis: focus on the multifaceted Notch signalling pathway","volume":"28","author":"Condorelli","year":"2021","journal-title":"J\u00a0Biomed Sci"},{"key":"10.1016\/j.jid.2023.05.024_bib38","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0092-8674(00)80127-0","article-title":"TGF\u03b21 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice","volume":"86","author":"Cui","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jid.2023.05.024_bib39","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.cell.2016.01.009","article-title":"TGF-beta tumor suppression through a lethal EMT","volume":"164","author":"David","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jid.2023.05.024_bib40","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/bjd.19421","article-title":"Heterogeneous addiction to transforming growth factor-beta signalling in recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma","volume":"184","author":"Dayal","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib41","first-page":"56","article-title":"Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar","volume":"146","author":"Desmouli\u00e8re","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2023.05.024_bib42","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jaad.2003.09.026","article-title":"Relative extent of skin involvement in inherited epidermolysis bullosa (EB): composite regional anatomic diagrams based on the findings of the National EB Registry, 1986 to 2002","volume":"50","author":"Devries","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib43","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13023-019-1262-7","article-title":"EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa","volume":"14","author":"Diociaiuti","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2023.05.024_bib44","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/cncr.23615","article-title":"Interleukin-6 predicts recurrence and survival among head and neck cancer patients","volume":"113","author":"Duffy","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jid.2023.05.024_bib45","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1188\/14.CJON.426-431","article-title":"Preventing infections during cancer treatment: development of an interactive patient education website","volume":"18","author":"Dunbar","year":"2014","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.jid.2023.05.024_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-238966","article-title":"Successful use of immunotherapy to treat advanced cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa","volume":"14","author":"Duong","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jid.2023.05.024_bib47","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2147\/CCID.S232547","article-title":"From clinical phenotype to genotypic modelling: incidence and prevalence of recessive dystrophic epidermolysis bullosa (RDEB)","volume":"12","author":"Eichstadt","year":"2019","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib48","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3389\/fonc.2019.01186","article-title":"Mechanisms underlying the anti-inflammatory and immunosuppressive activity of Ruxolitinib","volume":"9","author":"Elli","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.jid.2023.05.024_bib49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","article-title":"Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner","volume":"17","author":"Erez","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2023.05.024_bib50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/jamadermatol.2018.4673","article-title":"Assessment of the timing of milestone clinical events in patients with epidermolysis bullosa from North America","volume":"155","author":"Feinstein","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib51","first-page":"213","article-title":"Immune disregulation in cutaneous squamous cell carcinoma of patients with recessive dystrophic epidermolysis bullosa: a single pilot study","volume":"12","author":"Filoni","year":"2022","journal-title":"Life (Basel)"},{"key":"10.1016\/j.jid.2023.05.024_bib52","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/jdv.16022","article-title":"Morphological and morphometric analysis of cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a retrospective study","volume":"34","author":"Filoni","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2023.05.024_bib53","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/jamadermatol.2016.2473","article-title":"Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the national epidermolysis bullosa registry","volume":"152","author":"Fine","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib54","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","article-title":"Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification","volume":"70","author":"Fine","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib55","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaad.2008.09.035","article-title":"Epidermolysis bullosa\u00a0and the risk of life-threatening cancers: the National EB Registry\u00a0experience, 1986\u20132006","volume":"60","author":"Fine","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib56","first-page":"2040","article-title":"Genitourinary complications of inherited epidermolysis bullosa: experience of the national epidermylosis bullosa registry and review of the literature","volume":"172","author":"Fine","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jid.2023.05.024_bib57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/J.JHSB.2004.07.006","article-title":"Pseudosyndactyly and musculoskeletal contractures in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry, 1986\u20132002","volume":"30","author":"Fine","year":"2005","journal-title":"J\u00a0Hand Surg Br"},{"key":"10.1016\/j.jid.2023.05.024_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2017.11.004","article-title":"Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas","volume":"66","author":"F\u00f6ll","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jid.2023.05.024_bib59","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.jid.2018.04.026","article-title":"Reduced microbial diversity is a feature of recessive dystrophic epidermolysis bullosa-involved skin and wounds","volume":"138","author":"Fuentes","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib60","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/pde.14802","article-title":"Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: a global cross-sectional survey","volume":"38","author":"Fulchand","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03401997","article-title":"Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase","volume":"8","author":"Govindarajan","year":"2002","journal-title":"Mol Med"},{"key":"10.1016\/j.jid.2023.05.024_bib62","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jid.2021.09.008","article-title":"Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa","volume":"142","author":"Gretzmeier","year":"2022","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2017.01.002","article-title":"Stromal microenvironment in type VII collagen-deficient skin: the ground for squamous cell carcinoma development","volume":"63","author":"Guerra","year":"2017","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jid.2023.05.024_bib64","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa2206663","article-title":"Trial of beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa","volume":"387","author":"Guide","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2023.05.024_bib65","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41591-022-01737-y","article-title":"In\u00a0vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial","volume":"28","author":"Gurevich","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2023.05.024_bib66","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI24399","article-title":"Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis","volume":"115","author":"Han","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2023.05.024_bib67","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/s41416-020-01044-8","article-title":"Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)","volume":"123","author":"Hanna","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jid.2023.05.024_bib68","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.3390\/ijms20112767","article-title":"TGF-beta-mediated epithelial-mesenchymal transition and cancer metastasis","volume":"20","author":"Hao","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2023.05.024_bib69","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bjd.18921","article-title":"Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility","volume":"183","author":"Has","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib70","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1111\/jdv.17629","article-title":"Practical management of epidermolysis bullosa: consensus clinical position statement from the European Reference Network for Rare Skin Diseases","volume":"35","author":"Has","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2023.05.024_bib71","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/jdv.18637","article-title":"Epidemiology of inherited epidermolysis bullosa in Germany","volume":"37","author":"Has","year":"2023","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2023.05.024_bib72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41584-019-0324-5","article-title":"Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases","volume":"16","author":"Hinz","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jid.2023.05.024_bib73","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1038\/ncomms6932","article-title":"Innate sensing of microbial products promotes wound-induced skin cancer","volume":"6","author":"Hoste","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2023.05.024_bib74","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1038\/jid.2015.291","article-title":"Intravenously administered recombinant human Type VII collagen derived from Chinese hamster ovary cells reverses the disease phenotype in recessive dystrophic epidermolysis bullosa mice","volume":"135","author":"Hou","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib75","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/exd.14411","article-title":"Immunological mechanisms underlying progression of chronic wounds in recessive dystrophic epidermolysis bullosa","volume":"30","author":"Huitema","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib76","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jid.2020.08.022","article-title":"Targeting\u00a0the jak\/signal transducer and activator of transcription 3 pathway\u00a0with ruxolitinib in a mouse model of recessive dystrophic epidermolysis bullosa-squamous cell carcinoma","volume":"141","author":"Jack\u00f3w","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib77","first-page":"19","article-title":"The cutaneous microbiome and wounds: new molecular targets to promote wound healing","author":"Johnson","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2023.05.024_bib78","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2023.05.024_bib79","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2023.05.024_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035546","article-title":"Polymerized laminin-332 matrix supports rapid and tight adhesion of keratinocytes, suppressing cell migration","volume":"7","author":"Kariya","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2023.05.024_bib81","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2009.144","article-title":"Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity","volume":"17","author":"Kern","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2023.05.024_bib82","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1159\/000508933","article-title":"Induced remission of metastatic squamous cell carcinoma with an immune checkpoint inhibitor in a patient with recessive dystrophic epidermolysis bullosa","volume":"13","author":"Khaddour","year":"2020","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.jid.2023.05.024_bib83","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/bjd.12272","article-title":"Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma","volume":"169","author":"Kim","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib84","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2340\/00015555-2781","article-title":"Epidemiology and outcome of squamous cell carcinoma in epidermolysis bullosa in Australia and New Zealand","volume":"98","author":"Kim","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"Suppl. 1","key":"10.1016\/j.jid.2023.05.024_bib85","first-page":"30","article-title":"Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa","volume":"25","author":"Kim","year":"2015","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib86","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/2326-6066.CIR-20-0431","article-title":"IL1\u03b2 promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin D.","volume":"9","author":"Kiss","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jid.2023.05.024_bib87","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1155\/2011\/153108","article-title":"TGFbeta-signaling in squamous cell carcinoma occurring in recessive dystrophic epidermolysis bullosa","volume":"34","author":"Knaup","year":"2011","journal-title":"Anal Cell Pathol (Amst)"},{"key":"10.1016\/j.jid.2023.05.024_bib88","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/msb.2013.17","article-title":"Global remodelling of cellular microenvironment due to loss of collagen VII","volume":"9","author":"K\u00fcttner","year":"2013","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.jid.2023.05.024_bib89","unstructured":"Laimer MS, South AP, Diem A, Ude-Schoder K, Mayr E, Kitzmuller S, et al. Rigosertib for locally advanced\/metastatic EB-associated SCC. Poster presented at: Austrian Society of Dermatology and Venereology Annual Conference. 26 September 2021; Salzburg, Vienna."},{"key":"10.1016\/j.jid.2023.05.024_bib90","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/pde.14444","article-title":"Characterization of wound microbes in epidermolysis bullosa: results from the epidermolysis bullosa clinical characterization and outcomes database","volume":"38","author":"Levin","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib91","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/exd.14281","article-title":"Over-expression of stromal periostin correlates with poor prognosis of cutaneous squamous cell carcinomas","volume":"30","author":"Lincoln","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib92","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1126\/science.aax0902","article-title":"Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signaling","volume":"367","author":"Loganathan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jid.2023.05.024_bib93","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4103\/idoj.idoj_554_21","article-title":"Topical gentamicin 0.1% promotes collagen 7 expression in recessive dystrophic epidermolysis bullosa","volume":"13","author":"Mahajan","year":"2022","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jid.2023.05.024_bib94","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.abd.2020.05.001","article-title":"Inherited epidermolysis bullosa: update on the clinical and genetic aspects","volume":"95","author":"Mariath","year":"2020","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib95","series-title":"A\u00a0phase 1\/2 study of genetically corrected, collagen VII expressing autologous human dermal fibroblasts injected into the skin of patients with recessive dystrophic epidermolysis bullosa (RDEB)","author":"Marinkovich","year":"2022"},{"key":"10.1016\/j.jid.2023.05.024_bib96","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv293","article-title":"Suppression of TGFbeta and angiogenesis by type VII collagen in cutaneous SCC","volume":"108","author":"Martins","year":"2016","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jid.2023.05.024_bib97","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1242\/jcs.042895","article-title":"Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen","volume":"122","author":"Martins","year":"2009","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.jid.2023.05.024_bib98","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGF\u03b2 in cancer","volume":"134","author":"Massagu\u00e9","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jid.2023.05.024_bib99","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.4049\/jimmunol.172.7.4275","article-title":"Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation","volume":"172","author":"McKarns","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2023.05.024_bib100","first-page":"448","article-title":"Wound healing deficits in severe generalized recessive dystrophic epidermolysis bullosa along anticancer treatment with cetuximab","volume":"17","author":"Medek","year":"2019","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.jid.2023.05.024_bib101","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.det.2010.01.004","article-title":"Infection and colonization in epidermolysis bullosa","volume":"28","author":"Mellerio","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jid.2023.05.024_bib102","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bjd.14104","article-title":"Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines","volume":"174","author":"Mellerio","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib103","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/biomedicines10010114","article-title":"Revertant mosaicism in epidermolysis bullosa","volume":"10","author":"Meyer-Mueller","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jid.2023.05.024_bib104","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/bjd.18639","article-title":"STAT3 targeting in dystrophic epidermolysis bullosa","volume":"182","author":"Mittapalli","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib105","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1158\/0008-5472.CAN-15-1348","article-title":"Injury-driven stiffening of the dermis expedites skin carcinoma progression","volume":"76","author":"Mittapalli","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2023.05.024_bib106","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-016-0489-9","article-title":"Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases","volume":"11","author":"Montaudi\u00e9","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2023.05.024_bib107","doi-asserted-by":"crossref","unstructured":"Munn LL. Cancer and inflammation [e-pub ahead of print]. Wiley Interdiscip Rev Syst Biol Med 2017; doi:10.1002\/wsbm.1370 (accessed October 26, 2022).","DOI":"10.1002\/wsbm.1370"},{"key":"10.1016\/j.jid.2023.05.024_bib108","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1158\/1078-0432.CCR-18-1122","article-title":"Keratinocyte carcinomas: current concepts and future research priorities","volume":"25","author":"Nagarajan","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2023.05.024_bib109","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature14052","article-title":"Commensal-dendritic-cell interaction specifies a unique protective skin immune signature","volume":"520","author":"Naik","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jid.2023.05.024_bib110","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-11-2996","article-title":"Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa","volume":"72","author":"Ng","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2023.05.024_bib111","doi-asserted-by":"crossref","first-page":"E705","DOI":"10.1073\/pnas.1709111115","article-title":"Impaired lymphoid extracellular matrix impedes antibacterial immunity in epidermolysis bullosa","volume":"115","author":"Nystr\u00f6m","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jid.2023.05.024_bib112","doi-asserted-by":"crossref","first-page":"737272","DOI":"10.3389\/fgene.2021.737272","article-title":"Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers","volume":"12","author":"Nystr\u00f6m","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.jid.2023.05.024_bib113","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.15252\/emmm.201505061","article-title":"Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms","volume":"7","author":"Nystr\u00f6m","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jid.2023.05.024_bib114","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1172\/JCI68127","article-title":"Collagen VII plays a dual role in wound healing","volume":"123","author":"Nystr\u00f6m","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2023.05.024_bib115","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1093\/hmg\/ddu102","article-title":"Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-beta signalling in modifying disease severity","volume":"23","author":"Odorisio","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jid.2023.05.024_bib116","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/ijd.16157","article-title":"Surgical management and oncological follow-up of cutaneous squamous cell carcinomas arising in epidermolysis bullosa patients","volume":"61","author":"Paganelli","year":"2022","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib117","doi-asserted-by":"crossref","first-page":"672521","DOI":"10.3389\/fimmu.2021.672521","article-title":"PDCD1 polymorphisms may predict response to anti-PD-1 blockade in patients with metastatic melanoma","volume":"12","author":"Parakh","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2023.05.024_bib118","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1083\/jcb.111.2.743","article-title":"Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in\u00a0vitro","volume":"111","author":"Pepper","year":"1990","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jid.2023.05.024_bib119","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/bjd.20958","article-title":"The epidemiology of epidermolysis bullosa in England and Wales: data from the national epidermolysis bullosa database","volume":"186","author":"Petrof","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jdermsci.2020.10.009","article-title":"Aberrant recruitment of leukocytes defines poor wound healing in patients with recessive dystrophic epidermolysis bullosa","volume":"100","author":"Phillips","year":"2020","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2023.05.024_bib121","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jamadermatol.2020.0304","article-title":"Pembrolizumab for treatment of a patient with multiple cutaneous squamous cell carcinomas and recessive dystrophic epidermolysis bullosa","volume":"156","author":"Piccerillo","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib122","doi-asserted-by":"crossref","first-page":"188356","DOI":"10.1016\/j.bbcan.2020.188356","article-title":"Fibrosis and cancer: a strained relationship","volume":"1873","author":"Piersma","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.jid.2023.05.024_bib123","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa073770","article-title":"TP53 mutations and survival in squamous-cell carcinoma of the head and neck","volume":"357","author":"Poeta","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2023.05.024_bib124","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2023.05.024_bib125","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/bjd.12715","article-title":"High levels of type VII collagen expression in recessive dystrophic epidermolysis bullosa cutaneous squamous cell carcinoma keratinocytes increases PI3K and MAPK signalling, cell migration and invasion","volume":"170","author":"Pourreyron","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib126","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1038\/sj.jid.5700878","article-title":"Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression","volume":"127","author":"Pourreyron","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib127","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/exd.13979","article-title":"Epidermolysis bullosa: advances in research and treatment","volume":"28","author":"Prodinger","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib128","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1038\/jid.2010.243","article-title":"No evidence that human papillomavirus is responsible for the aggressive nature of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma","volume":"130","author":"Purdie","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib129","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/onc.2017.387","article-title":"IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma","volume":"37","author":"Qiao","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2023.05.024_bib130","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/jdv.15835","article-title":"Combined anti-inflammatory and low-dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa","volume":"34","author":"Reimer","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2023.05.024_bib131","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jid.2022.01.020","article-title":"Predominance of staphylococcus correlates with wound burden and disease activity in dystrophic epidermolysis bullosa: a prospective case-control study","volume":"142","author":"Reimer-Taschenbrecker","year":"2022","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib132","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/cells10030639","article-title":"Overview on the different patterns of tumor vascularization","volume":"10","author":"Ribatti","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jid.2023.05.024_bib133","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3875","article-title":"Cutaneous squamous cell carcinoma in epidermolysis bullosa: a 28-year retrospective study","volume":"101","author":"Robertson","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2023.05.024_bib134","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-0625.2007.00563.x","article-title":"Anchorless keratinocyte survival: an emerging pathogenic mechanism for squamous cell carcinoma in recessive dystrophic epidermolysis bullosa","volume":"16","author":"Rodeck","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib135","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1158\/0008-5472.CAN-21-0805","article-title":"Cutaneous human papillomaviruses and the risk of keratinocyte carcinomas","volume":"81","author":"Rollison","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2023.05.024_bib136","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jid.2023.05.024_bib137","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI45817","article-title":"Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors","volume":"122","author":"Salmon","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2023.05.024_bib138","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1038\/s41598-017-03456-8","article-title":"TGF-beta\/atRA-induced Tregs express a selected set of microRNAs involved in the repression of transcripts related to Th17 differentiation","volume":"7","author":"Schiavinato","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2023.05.024_bib139","doi-asserted-by":"crossref","first-page":"26775","DOI":"10.1016\/S0021-9258(18)47086-X","article-title":"Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system","volume":"269","author":"Schultz-Cherry","year":"1994","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2023.05.024_bib140","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jama.2016.15588","article-title":"Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa","volume":"316","author":"Siprashvili","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jid.2023.05.024_bib141","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archdermatol.2010.4","article-title":"Prevalence of a history of skin cancer in 2007: results of an incidence-based model","volume":"146","author":"Stern","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib142","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1046\/j.1523-1755.2002.00333.x","article-title":"Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation","volume":"61","author":"Strutz","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.jid.2023.05.024_bib143","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12881-020-01073-3","article-title":"Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis","volume":"21","author":"Sun","year":"2020","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jid.2023.05.024_bib144","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","article-title":"Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion","volume":"599","author":"Sun","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jid.2023.05.024_bib145","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1158\/2159-8290.CD-15-0344","article-title":"APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity","volume":"5","author":"Swanton","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2023.05.024_bib146","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12079-009-0074-2","article-title":"The interaction of thrombospondins with extracellular matrix proteins","volume":"3","author":"Tan","year":"2009","journal-title":"J\u00a0Cell Commun Signal"},{"key":"10.1016\/j.jid.2023.05.024_bib147","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature25492","article-title":"TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jid.2023.05.024_bib148","doi-asserted-by":"crossref","first-page":"842","DOI":"10.4161\/epi.28597","article-title":"Notch signaling genes: myogenic DNA hypomethylation and 5-hydroxymethylcytosine","volume":"9","author":"Terragni","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.jid.2023.05.024_bib149","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance","volume":"8","author":"Thomas","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2023.05.024_bib150","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1074\/jbc.M114.606186","article-title":"Myofibroblasts exhibit enhanced fibronectin assembly that is intrinsic to their contractile phenotype","volume":"290","author":"Torr","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2023.05.024_bib151","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/mt.2013.87","article-title":"Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure","volume":"21","author":"Wang","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2023.05.024_bib152","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/archderm.1991.01680070094012","article-title":"Nonmelanoma skin cancer mortality. A population-based study","volume":"127","author":"Weinstock","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib153","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3892\/ijo.2015.3060","article-title":"BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts","volume":"47","author":"Wen","year":"2015","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jid.2023.05.024_bib154","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","article-title":"TIM3 comes of age as an inhibitory receptor","volume":"20","author":"Wolf","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2023.05.024_bib155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41389-021-00302-5","article-title":"TGF-beta1-mediated transition of resident fibroblasts to cancer-associated fibroblasts promotes cancer metastasis in gastrointestinal stromal tumor","volume":"10","author":"Yoon","year":"2021","journal-title":"Oncogenesis"},{"key":"10.1016\/j.jid.2023.05.024_bib156","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.3390\/ijms20092256","article-title":"Activated fibroblast program orchestrates tumor initiation and progression; molecular mechanisms and the associated therapeutic strategies","volume":"20","author":"Yoshida","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2023.05.024_bib157","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2023.05.024_bib158","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1038\/s41467-018-05768-3","article-title":"The tyrosine phosphatase SHP2 controls TGFbeta-induced STAT3 signaling to regulate fibroblast activation and fibrosis","volume":"9","author":"Zehender","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2023.05.024_bib159","doi-asserted-by":"crossref","first-page":"10325","DOI":"10.1158\/0008-5472.CAN-06-1594","article-title":"p16INK4a modulates p53 in primary human mammary epithelial cells","volume":"66","author":"Zhang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2023.05.024_bib160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.8140422","article-title":"Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6","volume":"264","author":"Zhong","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jid.2023.05.024_bib161","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1590\/abd1806-4841.20153206","article-title":"Nutritional aspects of children and adolescents with epidermolysis bullosa: literature review","volume":"90","author":"Zidorio","year":"2015","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jid.2023.05.024_bib162","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1186\/s12885-018-4587-z","article-title":"TGF-beta signaling promotes tumor vasculature by enhancing the pericyte-endothelium association","volume":"18","author":"Zonneville","year":"2018","journal-title":"BMC Cancer"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23023382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23023382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:52:39Z","timestamp":1762206759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X23023382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":156,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0022202X23023382"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2023.05.024","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type VII Collagen Deficiency in the Oncogenesis of Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2023.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}